Abstract: Generative AI based on large-language models is significantly impacting software development through IDE assistants, cloud-based APIs, and interactive chatbots for coding assistance. It ...

MOTHERS of Special Heroes (MOSH) marked their fourth anniversary with a touching Christmas celebration held on December 11 at the Church of Christ in Bulawayo. The event brought together families, ...

Chlorpyrifos has undergone dramatic changes in its market trajectory, from a blockbuster proprietary molecule to a globally traded generic active ingredient. AgriBusiness Global spoke with Ram ...

Jacksonville's Museum of Science and History still needs to raise tens of millions of dollars for its new riverfront location. MOSH has proposed reducing on-site parking to cut construction costs by ...

With no negotiations, no oversight and no clarity about Iran’s stock of nuclear material, many in the region fear another war with Israel is inevitable. By Steven Erlanger Steven Erlanger has written ...

Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

The U.S. Food and Drug Administration has introduced a new pilot program aimed at accelerating the review process for generic drugs that are both tested and produced entirely within the United States.

Against a backdrop of tariff updates and a drug pricing deal from the Trump administration, the FDA charted a pair of moves this week in its push to make drug manufacturing more attractive in the U.S.

With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...